Self-renewal as a therapeutic target in human colorectal cancer

…, NN Iscove, CH Arrowsmith, E Szentgyorgyi… - Nature medicine, 2014 - nature.com
Tumor recurrence following treatment remains a major clinical challenge. Evidence from
xenograft models and human trials indicates selective enrichment of cancer-initiating cells (CICs…

International study group on rectal cancer regression grading: interobserver variability with commonly used regression grading systems

…, A Rullier, S Serra, N Shepherd, E Szentgyorgyi… - Human pathology, 2012 - Elsevier
The aim of this study was to ascertain the level of concordance among gastrointestinal
pathologists for regression grading in rectal cancers treated with neoadjuvant chemoradiation. …

Regression grading in neoadjuvant treated pancreatic cancer: an interobserver study

…, N Dhani, S Hafezi-Bakhtiari, E Szentgyorgyi… - Journal of Clinical …, 2017 - jcp.bmj.com
Aim Several regression grading systems have been proposed for neoadjuvant
chemoradiation-treated pancreatic ductal adenocarcinoma (PDAC). This study aimed to examine the …

Gastric Biopsies: The Gap between Evidence-Based Medicine and Daily Practice in the Management of GastricHelicobacter pyloriInfection

H El-Zimaity, S Serra, E Szentgyorgyi… - Canadian Journal of …, 2013 - hindawi.com
BACKGROUND: Many consider histology to be the gold standard forHelicobacter pyloridetection.
Because the number and distribution ofH pyloriorganisms vary, particularly in patients …

The Celiac Disease and Diabetes-Dietary Intervention and Evaluation Trial (CD-DIET) protocol: a randomised controlled study to evaluate treatment of asymptomatic …

…, S Kirsch, BA Perkins, M Cino, E Szentgyorgyi… - BMJ open, 2015 - bmjopen.bmj.com
Introduction Coeliac disease (CD) is an autoimmune condition characterised by gluten-induced
intestinal inflammation, and observed at a 5–10 fold greater prevalence in type 1 …

Administration of hypoxia-activated prodrug evofosfamide after conventional adjuvant therapy enhances therapeutic outcome and targets cancer-initiating cells in …

…, A Kreso, R Wolman, E Szentgyorgyi… - Clinical Cancer …, 2018 - AACR
Purpose: Cancer-initiating cells (C-IC) have been described in multiple cancer types, including
colorectal cancer. C-ICs are defined by their capacity to self-renew, thereby driving tumor …

Inhibin-expressing clear cell neuroendocrine tumor of the ampulla: an unusual presentation of von Hippel–Lindau disease

H Gucer, E Szentgyorgyi, S Ezzat, SL Asa, O Mete - Virchows Archiv, 2013 - Springer
von Hippel–Lindau (VHL) disease is a hereditary autosomal dominant disorder associated
with deletions or mutations in the VHL tumor suppressor gene. Characteristically, up to 60 % …

Gastric foveolar dysplasia: a survey of reporting habits and diagnostic criteria

…, K Sheahan, A Srivastava, E Szentgyorgyi… - Pathology, 2017 - Elsevier
This study aimed to ascertain views, incidence of reporting and diagnostic criteria for gastric
foveolar dysplasia. A questionnaire, a post-questionnaire discussion and microscopic …

A multi-centre pathologist survey on pathological processing and regression grading of colorectal cancer resection specimens treated by neoadjuvant chemoradiation

…, A Rullier, S Serra, N Shepherd, E Szentgyorgyi… - Virchows Archiv, 2012 - Springer
To ascertain the approach and degree of consensus of pathologists in the handling and
regression grading of colorectal cancer resection specimens treated with neoadjuvant …

Pathological grading of regression: an International Study Group perspective

…, C Rowsell, A Rullier, S Serra, E Szentgyorgyi… - Journal of clinical …, 2012 - jcp.bmj.com
In this issue of the Journal of Clinical Pathology, MacGregor, Maughan and Sharma1 discuss
the value and utility of pathological grading of regression from an oncologist’s point of view…